Jefferies believes aggressive moves by incumbents and entry of new players in the QC space can result in higher discounting ...

Sheila Kahyaoglu, Jefferies aerospace and defense analyst, joins CNBC's The Exchange to discuss why her firm increased the ...

Jefferies analyst Daniel Fannon maintained a Buy rating on Goldman Sachs Group (GS – Research Report) today and set a price target of $667.00.

Jefferies downgraded Blue Star Ltd. to 'hold' from 'buy' after the stock rallied 140% in calendar year 2024. The stock is now ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...

Jefferies has made some changes to its well-respected Franchise Picks list. Three of its picks for 2025 look like outstanding ...

Jefferies analyst Brent Thill upgraded Procore (PCOR) to Buy from Hold with a price target of $100, up from $80. The firm expects a favorable ...

Topgolf Callaway stock rose Thursday after Jefferies analysts raised their rating on shares of the golf equipment ...

The yield on 10-year Bunds edged up and Jefferies said it had a buy level at 2.40%, so would prefer “a long position at [the] current level.” ...

After the 140 percent rally of Blue Star shares, there is limited upside potential for the stock, said Jefferies.

Key stocks recommended by Jefferies for 2025 include Mankind Pharma, JB Chemicals, and Sun Pharmaceutical Industries.

The global brokerage firm revised the target lower, citing increasing competition as a threat to the online food aggregator’s ...